UnitedHealth Medical Cost Ratio Hits 89.1% Despite Q4 Earnings Beat
UnitedHealth’s medical cost ratio rose to 89.1% in 2025, pressured by rising medical costs and elevated debt and interest expenses. Despite a Q4 earnings beat and steady revenue growth driven by Optum and UnitedHealthcare, shares have declined 3.9% over six months and remain overvalued relative to industry.
1. Rising Medical Cost Ratio and Valuation
UnitedHealth’s medical cost ratio climbed to 89.1% in 2025 due to escalating medical expenses while elevated debt and interest expenses constrain financial flexibility. Shares slipped 3.9% over the past six months compared with a 4.6% industry decline, and the stock trades at a premium to peers.
2. Q4 Earnings Beat and Revenue Drivers
The company beat fourth-quarter earnings estimates, powered by steady revenue growth across UnitedHealthcare and Optum segments. Strong cash flows supported significant shareholder returns despite cost headwinds.
3. Optum Growth and Membership Expansion
Optum remains a growth engine with pharmacy services, technology integration and government solutions driving margin expansion. Commercial membership growth further bolstered margins, reflecting rising healthcare demand.